PRINCETON, N.J., Dec. 15, 2016 /PRNewswire/ -- Geistlich Pharma North America, Inc. is proud to announce with their symposium sponsors an interactive and didactic program covering topics around peri-implantitis. This three-day event will feature a surgical and non-surgical hands-on workshop as well as general sessions from world-class presenters. Come learn from leaders in our industry with expertise on the prevention, diagnosis and treatment in peri-implantitis complications. This multidisciplinary symposium is for all dental professionals who are responsible or interested in the placement, maintenance, restoration and preservation of dental implants.
We encourage you to learn more about this program by visiting the following website: http://www.geistlich-na.com/en-us/events/symposium/peri-implantitis-symposium/.
Advancing Awareness, Collaboration and Achievable Outcomes
"Peri-implantitis is not a regional problem; it's a worldwide problem, so coming together [at this symposium] for hands-on training and an honest discussion about what we know and what we still need to learn is what this conference will be all about. It will stress a multidisciplinary approach with both surgeon and restorative dentists learning how collaboration on diagnosis and treatment can increase successful outcomes." – Dr. Stuart Froum, Co-organizing Chairman
Global exchange of high-level ideas and information will be carried throughout the event. The hands-on workshops, on Friday, June 9th, will be limited in attendance and are sure to sell out quickly. These interactive programs will review "Non-Surgical Periodontal Therapy", presented by Dr. Marisa Roncati of Italy and "Corrections for the Prevention and Management of Peri-Implant Diseases", presented by Prof. Dr. Frank Schwarz of Germany.
General Sessions will commence on Saturday, June 10th and Sunday, June 11th and will include topics such as:
More details on the symposium can be found at http://www.geistlich-na.com/en-us/events/symposium/peri-implantitis-symposium/. We hope to see you there!
About Peri-Implantitis -
Peri-implant disease is a pathological condition around dental implants with an incident rate that varies widely based on the assessment protocol. The disease ranges from reversible mucositis lesions (reflecting a host's response to bacterial challenge) to non-reversible peri-implantitis, where significant alveolar bone has been lost.1 In the restoration of implants and in the treatment of peri-implant infections, an analogous approach to systematic periodontal therapy should be considered. Learn more about peri-implantitis by following this link, http://www.geistlich-na.com/en-us/professionals/therapeutic-area/peri-implantitis/scientific-background/.
About Geistlich Pharma North America, Inc. -
Geistlich Pharma North America continues to lead dental regeneration with its expanding family of predictable and proven biomaterials, including bone substitutes Geistlich Bio-Oss® and Geistlich Bio-Oss Collagen®, a resorbable bilayer collagen membrane, Geistlich Bio-Gide®, a soft-tissue regeneration collagen matrix, Geistlich Mucograft®, and introducing, Geistlich Mucograft® Seal, a 3D collagen matrix designed for soft-tissue regeneration around an implant or prosthetic. With over 160 years of Swiss tradition, Geistlich Biomaterials has been a trusted partner for dental regenerative solutions based upon continuous innovation, scientific collaboration, and a commitment to successful outcomes.
1 Lang NP et al., Ann Periodontol. 1997 Mar;2(1):343-356
SOURCE Geistlich Pharma North America, Inc.
